Initial Experience with<sup>68</sup>Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer
Vadim S. Koshkin(UCSF Helen Diller Family Comprehensive Cancer Center), Thomas A. Hope(Fondazione IRCCS Istituto Nazionale dei Tumori), Domenique Escobar(University of California, San Francisco), Jonathan Chou(UCSF Helen Diller Family Comprehensive Cancer Center), Sima P. Porten(City College of San Francisco), Maya Aslam(University of California, San Francisco), Brad Kline(University of California, San Francisco), Vipul Kumar(University of California, San Francisco), Terence W. Friedlander(University of California, San Francisco), Rahul Aggarwal(UCSF Helen Diller Family Comprehensive Cancer Center), Maxwell V. Meng(University of California, San Francisco), Matthew R. Cooperberg(University of California, San Francisco), Ivan de Kouchkovsky(University of California, San Francisco)
Cited by 26
Related Papers
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma
|JAMA Oncology|2017|846
The Changing Face of Prostate Cancer
|Journal of Clinical Oncology|2005|322
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer
|European Urology|2017|218
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
|JAMA Oncology|2021|185
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
|Journal for ImmunoTherapy of Cancer|2018|184